Results 161 to 170 of about 4,926 (186)

miRNAs in Glomerular Diseases: From Pathogenic Insight to Therapeutic Potential: A Narrative Review. [PDF]

Cells
Apetrii M, Costache AD, Costache Enache II, Voroneanu L, Covic AS, Kanbay M, Scripcariu DV, Covic A.   +7 more
europepmc   +1 more source

Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential. [PDF]

Int J Nanomedicine
Yuan S, Jin M, Zhang Y, Zhang M, Yuan M, Ding X, Wang J.   +6 more
europepmc   +1 more source

MicroRNAs modulated by DPP-4 inhibitor and bedtime NPH insulin therapy in individuals with type 2 diabetes. [PDF]

Front Endocrinol (Lausanne)
Santos AS, Bando SY, Correa Giannella MLC, da Silva MER.   +3 more
europepmc   +1 more source

Bee venom promotes exosome secretion and alters miRNA cargo in T cells. [PDF]

Open Life Sci
Cui Z, Zhou Z, Sun Z, Duan J, Liu R, Qi C, Yan C.   +6 more
europepmc   +1 more source

The Growing Significance of microRNAs in Osteoporosis. [PDF]

Cells
Sarkar A, Sarkar S, Anwar A, Kim JW, Shim JH, John AA.   +5 more
europepmc   +1 more source

miR-188-5p accelerates intervertebral disc degeneration by mediating P4HB to regulate ferroptosis in nucleus pulposus cells. [PDF]

Eur J Med Res
Yan J, Miao S, Zhu Y, Gao Y, Chen R, Gong Y, Zhou Q.   +6 more
europepmc   +1 more source

TTF-1-regulated miR-532-5p targets KRAS and MKL2 oncogenes and induces　apoptosis in lung adenocarcinoma cells

TTF-1-regulated miR-532-5p targets KRAS and MKL2 oncogenes and induces　apoptosis in lung adenocarcinoma cells
openaire  

Some of the next articles are maybe not open access.

Related searches:

Identification of Mir-532-5p As a Reliable miRNA Reference in Acute Lymphoblastic Leukemia

Blood, 2023
In acute lymphoblastic leukemia (ALL) cure rates have reached >90%, however, therapy resistance and relapses occur. Hence, the major interest in leukemia research is the understanding of ALL biology and, based on that, the development of new targeted therapies. As patient-derived xenograft (PDX) mouse models, such as the NOD/SCID/
Teresa Mack, Klaus-Michael Debatin, Lueder Hinrich Meyer, Vera Münch   +3 more
openaire   +1 more source